Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns

Vittorio Gebbia, Alberto Firenze, Vittorio Gebbia, Paolo Tralongo, Dario Piazza, Alessandro Pellegrino, Massimiliano Spada, Livio Blasi, Carmelo Iacono, Roberto Bordonaro, Alberto Firenze, Debora Piazza, Roberto Bordonaro

Risultato della ricerca: Articlepeer review


To contain COVID-19 spread, Italy is under a global lockdown since February 21, 2020, except for health services and food supply. In this scenario, growing apprehension concerning legal consequences is rising among health professionals due to several ethical and legal questions. Even if medical ethicists may approve patients’ prioritization protocols, hospitals and health professionals remain highly exposed to liability. The so-called smart-working may be very useful, but it may harbor potential legal harms for health personnel and patients and safety. Moreover, personal umbrella policies also often exclude liability arising out of the transmission of a communicable disease, especially a pandemic state, is declared. Under the pressure of medical associations, Italian Government political forces have very recently presented an amendment to the recently released ordinances for the COVID-19 emergency aimed to reduce medical liability. Presumably, similar epidemics or other wide-scale similar events may happen again in an unpredictable future. Therefore, more articulated legal regulations are strongly needed starting from lessons learned from this epidemic.
Lingua originaleEnglish
Numero di pagine3
RivistaJournal of Cancer Policy
Stato di pubblicazionePublished - 2020

All Science Journal Classification (ASJC) codes

  • Oncology
  • Health Policy

Cita questo